By the end of 2024, the company had more than 80 projects for drugs under development (calculated by indications)

• 23

  Self-developed small molecule innovator drug

• 19

  Self-developed innovative biologics

• 21

  In-licensing innovator drugs

• 12

  Self-developed biosimilars

• 5

  Vaccines in the pipeline